| Original language | English (US) |
|---|---|
| Pages (from-to) | 243-264 |
| Number of pages | 22 |
| Journal | Advances in Internal Medicine |
| Volume | 34 |
| State | Published - 1989 |
| Externally published | Yes |
Fingerprint
Carcinogenicity Tests
DNA Adducts
Carcinogens
DNA
ASJC Scopus subject areas
- Medicine(all)
Cite this
Koh, H. K., Prout, M. N., & Groopman, J. D. (1989). Carcinogen monitoring by DNA adduct methodology in humans: clinical perspectives for the 1990s. Advances in Internal Medicine, 34, 243-264.
Carcinogen monitoring by DNA adduct methodology in humans : clinical perspectives for the 1990s. / Koh, H. K.; Prout, M. N.; Groopman, John Davis.
In: Advances in Internal Medicine, Vol. 34, 1989, p. 243-264.Research output: Contribution to journal › Article
Koh, HK, Prout, MN & Groopman, JD 1989, 'Carcinogen monitoring by DNA adduct methodology in humans: clinical perspectives for the 1990s.', Advances in Internal Medicine, vol. 34, pp. 243-264.
Koh HK, Prout MN, Groopman JD. Carcinogen monitoring by DNA adduct methodology in humans: clinical perspectives for the 1990s. Advances in Internal Medicine. 1989;34:243-264.
@article{d12cc32c8ee545e1b3978a30e440985b,
title = "Carcinogen monitoring by DNA adduct methodology in humans: clinical perspectives for the 1990s.",
author = "Koh, {H. K.} and Prout, {M. N.} and Groopman, {John Davis}",
year = "1989",
language = "English (US)",
volume = "34",
pages = "243--264",
journal = "Advances in Internal Medicine",
issn = "0065-2822",
publisher = "Year Book Medical Publishers",
}
TY - JOUR
T1 - Carcinogen monitoring by DNA adduct methodology in humans
T2 - clinical perspectives for the 1990s.
AU - Koh, H. K.
AU - Prout, M. N.
AU - Groopman, John Davis
PY - 1989
Y1 - 1989
UR - http://www.scopus.com/inward/record.url?scp=0024569305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024569305&partnerID=8YFLogxK
M3 - Article
VL - 34
SP - 243
EP - 264
JO - Advances in Internal Medicine
JF - Advances in Internal Medicine
SN - 0065-2822
ER -